Erectile Dysfunction Drugs Market Overview
The erectile dysfunction drugs market is projected to reach USD 2930 million during the forecast period. However, the same market is predicted to generate the market value at a CAGR of 3.5% in the forecast timeframe.
The worldwide erectile dysfunction drugs market is driven because of the patent expiry of a number of blockbuster drugs and the increasing geriatric population. Moreover, the rising number of men suffering from erectile dysfunction disorder is another major growth driving factor for the global market. Additionally, poor patient adherence to erectile dysfunction drugs can bring significant growth opportunities for the key players and the manufacturers of the market. Further, the investment is increasing in the research and developmental activities as well, as new product launches are occurring, which is expected to bring lucrative opportunities for the worldwide erectile dysfunction drugs market.
However, the development of the erectile dysfunction drugs market might be hampered due to the absence of training, the absence of mindfulness, social untouchability, solid strict convictions, and low financial status.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1313
Erectile Dysfunction Drugs Market Segmentation
As per the erectile dysfunction drugs market report, the market has been classified in terms of end-users and drugs.
On the basis of the end-user segment, the Erectile Dysfunction Drugs industry has been segregated into medical clinic drug stores, retail drug stores, and online drug stores. However, the medical clinic drug store is expected to grow the market share in the forecast period due to the expanding pool of patients because of the growth of patient schooling and mindfulness.
Based on the drug segment, the market for Erectile Dysfunction Drugs has been classified intozydena (udenafil),staxyn/Levitra (vardenafil), Cialis (tadalafil), Viagra (sildenafil citrate), vitaros (alprostadil cream), stendra/spedra (avanafil), and others. Among these, the Cialis segment is growing the demand for the Erectile Dysfunction Drugs industry in the forecast period. In general, the Cialis has more capacity to give an erection for a longer period as compared to the viagra. Usually, Viagra gives 4 to 6 hours of erection, while Cialis give18 hours of erection.
Erectile Dysfunction Drugs Market Regional Analysis
Regionally, the erectile dysfunction drugs market has been classified into different regions such as the Americas, the Middle East & Africa, the Asia-Pacific, Europe, and others.
Among these, the North American market for erectile dysfunction drugs is projected to lead the global market during the forecast period because of the presence of better healthcare infrastructure, rise in cases of ED, and increasing geriatric population in the region. According to the 2021 report of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), nearly 30 million men population have gone through ED in the United States. Thus, the rising prevalence of ED and the highest rate of self-reported ED in the US is projected to enhance the market growth during the research period.
Erectile Dysfunction Drugs Market Competitive Analysis:
Top key players in the erectile dysfunction drugs market include
- Apricus Biosciences Inc.
- K. Chemicals Co. Ltd.
- Dong-A Pharmaceutical Co. Ltd.
- Eli Lilly & Co.
- Bayer AG
- Pfizer Inc.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/erectile-dysfunction-drugs-market-1313
In March 2019, Tadalafil tablets were launched by Dr. Reddy’s Laboratories. This product has been proposed to treat erectile dysfunction among the US population. It is basically the therapeutic equivalent generic version of Cialis (tadalafil) tablets in 20 mg,10 mg,5 mg, and 2.5 mg.
Browse Related Reports at:
Health Insurance Market Research Report – Global Forecast till 2027
Telehealth Market Research Report – Global Forecast till 2027
Active Pharmaceutical Ingredients Market Research Report – Global Forecast till 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071